AG00BEA9

301836-43-1 | 4-(4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)-5-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE

Chemical structure of 4-(4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)-5-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE, CAS 301836-43-1
AG00BEA9
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 301836-43-1
Catalog Number AG00BEA9(AGN-PC-0LT9VO)
Chemical Name 4-(4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)-5-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE
IUPAC Name 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide
InChI InChI=1S/C23H18N4O3/c24-22(28)14-4-6-15(7-5-14)23-26-20(21(27-23)17-3-1-2-10-25-17)16-8-9-18-19(13-16)30-12-11-29-18/h1-10,13H,11-12H2,(H2,24,28)(H,26,27)
InChI Key DPDZHVCKYBCJHW-UHFFFAOYSA-N
MDL Number MFCD09037526
Molecular Formula C23H18N4O3
Molecular Weight 398.4140
SMILES O1C2=C(OCC1)C=C(C=C2)C=2N=C(NC2C2=NC=CC=C2)C2=CC=C(C(=O)N)C=C2
Synonyms
4-(4-(2,3-dihydrobenzo(1,4)dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide, D 4476, D-4476, D4476 cpd, 301836-43-1, D4476, CK1 Inhibitor, D 4476, casein kinase I inhibitor, 4-(4-(2,3-Dihydrobenzo[1,4]dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide, Casein Kinase I Inhibitor, D4476, D-4476, 4-(4-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide, CHEMBL410456, DPDZHVCKYBCJHW-UHFFFAOYSA-N, Benzamide,4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]-, 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide, InSolution™ Casein Kinase I Inhibitor, D4476, C23H18N4O3, 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl]benzamide, 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide, AC1O4WCQ, K00227, MLS006010815, SCHEMBL373737, GTPL5940, CHEBI:91448, CTK4G4622, AOB6860, DTXSID60423554, EX-A538, HMS3229C20, HMS3266B22, HMS3648M06, HMS3677F18, BCP09776, 3568AH, BDBM50229971, FD5005, IN1394, MFCD09037526, s7642, ZINC14806405, AKOS024457325, CCG-206826, CCG-208141, CS-1080, QC-5031, KS-0000181D, NCGC00242498-01, NCGC00242498-03, 4CA-0428, AK544283, BC600619, D4476, >=98% (HPLC), solid, HY-10324, SMR004701747, AB0087813, FT-0700282, W-5391, D4476 (D-4476), SR-01000946388, J-017815, SR-01000946388-1, BRD-K09132007-001-01-8, BRD-K09132007-001-04-2, 4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]-benzamide, 4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)1H-imidazol-2-yl]benzamide, 4-[4-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]-benzamide, 4-[4-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]benzamide, D00JGL, D4476 cpd, CID6419753, A3342, A13949, C493177, 4-(4-(2,3-dihydrobenzo(1,4)dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide, Purvalanol A; 2-(1R-Isopropyl-2-hydroxyethylamino)-6-(3-chloroanilino)-9-isopropyl-purine,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited